Tip Sheet: Nutrition for people receiving stem cell transplants, art therapy for cancer patients, treating a rare type of colon cancer — and graduate student awards announced SEATTLE — April 2, 2025 — ...

National Comprehensive Cancer Network® (NCCN®) Guidelines for colon and rectal cancer were updated to include ctDNA as a prognostic marker and high risk factor for recurrence NCCN guideline for merkel ...

Researchers uncover important insights into T cell abundance and subpopulations in colorectal cancer that support immunotherapy-based approaches for treatment.

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients with mantle cell lymphoma.

Colorectal cancer (CRC) remains a major global health burden, being one of the most prevalent cancers with high mortality rates. Despite advances in conventional treatment modalities, patients with ...

In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role of goblet cells—specialized cells that line the gut—in maintaining a ...

Disruptions to goblet cell functions can contribute to gastrointestinal diseases like colorectal cancer and inflammatory bowel disease, making them a promising therapeutic target for maintaining ...

In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role of goblet cells - specialized cells that line the gut - in maintaining a ...

A new study in mice has shown that intermittent fasting may help stimulate cell regeneration but also carry the risk of stimulating the formation of intestinal tumors.

Scientists have found that early-stage colorectal cancer cells recruit the SOX17 gene to essentially become invisible to the immune system.

AGR2 variants were also identified in disorder resembling cystic fibrosis (Bertoli-Avella et al, 2022), raising the possibility that the mechanism identified here in colon goblet cells might be ...